In addition, productive type-I IFN–mediated antitumor immune responses require an intact STING signaling pathway within myeloid cells, including dendritic cells (DC) and macrophages, highlighting the critical role of STING signaling in innate immune cells to achieve robust and durable tumor rejection (13). Here, STING1 is linked to neoplasm.